• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC HEART VALVES DIVISION EVOLUT R TRANSCATHETER AORTIC VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED Back to Search Results
Model Number EVOLUTR-29
Device Problem Activation Failure (3270)
Patient Problems Low Blood Pressure/ Hypotension (1914); Insufficiency, Valvular (1926); Perforation (2001); Blood Loss (2597); Pericardial Effusion (3271)
Event Date 07/24/2020
Event Type  Injury  
Manufacturer Narrative
Product analysis: the product remains implanted; therefore, no product analysis could be performed.  conclusion: paravalvular leak (pvl) can be caused by a variety of factors, including valve positioning, patient anatomy, calcification level or presence of pre-existing patient conditions.In this case, it was reported that the moderate pvl was noted post implant and the valve was not fully expanded.This indicated that incomplete frame expansion could be a contributing factor for the pvl.A balloon aortic valvuloplasty (bav) was performed, pvl had reduced to trivial and it was noted that the valve had expanded.Multiple factors can affect frame expansion, such as patient anatomy (e.G., calcification location and levels) and procedure related factors (e.G., valve positioning).Based on the information provided, an assignable root cause of the frame incomplete expansion could not be conclusively determined.The device history record and associated frame lot was reviewed and showed that this device met all manufacturing specifications for final product released for distribution.No issues were identified that would have impacted this event.There is no information to suggest a device quality deficiency that may have caused or contributed to this event.During vascular closure, hypotension was noted despite medication administration.Echocardiogram revealed a mild pericardial effusion which worsened over the course of ten minutes.Hypotension is a known potential adverse effect per instructions for use (ifu).It is an effect that is highly dependent on the patient's pre-procedural condition and can occur despite a normally-functioning device or model implant procedure.Pericardial effusion is also a known effect that can occur after cardiac procedures.A conclusive cause of the hypotension and effusion could not be determined from the limited information available.In this case, a pericardiocentesis was performed and hemodynamics stabilized with no further blood loss.It was suspected that an annular tear or perforation caused the bleeding.Per the physician, it was thought that the perforation was caused by the post-implant bav.This event did not indicate device misuse or malfunction.If information is provided in the future, a supplemental report will be issued.
 
Event Description
Medtronic received information that prior to the implant of this transcatheter bioprosthetic valve, a balloon aortic valvuloplasty (bav) was performed.The valve was deployed successfully on the first attempt.Aortography revealed evidence that the valve did not fully expand and echocardiogram indicated mild to moderate paravalvular leak (pvl).A post-implant bav was performed using a 24 mm non-medtronic balloon.Following bav, pvl had reduced to trivial and it was noted that the valve had expanded.During vascular closure, hypotension was noted despite medication administration.Echocardiogram revealed a mild pericardial effusion which worsened over the course of ten minutes.A pericardiocentesis was performed and hemodynamics stabilized with no further blood loss.It was suspected that an annular tear or perforation caused the bleeding.Per the physician, it was thought that the perforation was caused by the post-implant bav.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT R TRANSCATHETER AORTIC VALVE
Type of Device
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED
Manufacturer (Section D)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer (Section G)
MEDTRONIC HEART VALVES DIVISION
1851 e deere ave
santa ana CA 92705
Manufacturer Contact
paula bixby
8200 coral sea street ne
mounds view, MN 55112
7635055378
MDR Report Key10791200
MDR Text Key214746764
Report Number2025587-2020-03438
Device Sequence Number1
Product Code NPT
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
P130021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 11/05/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model NumberEVOLUTR-29
Device Catalogue NumberEVOLUTR-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/28/2020
Initial Date FDA Received11/05/2020
Date Device Manufactured01/03/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
Patient Age76 YR
-
-